CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Kelderman Kim Chief Executive Officer | Grant or award · Restricted Stock Units | +57,590 | 57,590 | ||
| 2026-08-17 | Kelderman Kim Chief Executive Officer | Grant or award · Restricted Stock Units | +93,582 | 93,582 | ||
| 2026-08-17 | Hippel James CFO | Grant or award · Restricted Stock Units | +22,438 | 22,438 | ||
| 2026-08-17 | Hippel James CFO | Grant or award · Restricted Stock Units | +36,459 | 36,459 | ||
| 2026-08-17 | Herr Amy E. Director | Grant or award · Restricted Stock Units | +1,381 | 1,381 | ||
| 2026-08-17 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Restricted Stock Units | +14,762 | 14,762 | ||
| 2026-08-17 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Restricted Stock Units | +23,985 | 23,985 | ||
| 2026-08-17 | Crouse Steven C. President - Diag & Spatial Bi | Grant or award · Restricted Stock Units | +8,702 | 8,702 | ||
| 2026-08-17 | Crouse Steven C. President - Diag & Spatial Bi | Grant or award · Restricted Stock Units | +14,140 | 14,140 | ||
| 2026-08-15 | Hippel James CFO | Option exercise | +9,980 | 174,694 | ||
| 2026-08-15 | Hippel James CFO | Shares withheld for taxes | −4,423 | $72.40 | $320K | 170,271 |
| 2026-08-15 | Hippel James CFO | Returned to the company · Performance Stock Options (Right to Buy) | −34,443 | 2,871 | ||
| 2026-08-15 | Hippel James CFO | Option exercise · Performance Restricted Stock Units | −1,067 | 12,798 | ||
| 2026-08-15 | Hippel James CFO | Returned to the company · Performance Restricted Stock Units | −12,798 | 0 | ||
| 2026-08-15 | Hippel James CFO | Option exercise · Restricted Stock Units | −4,010 | 4,011 | ||
| 2026-08-15 | Hippel James CFO | Option exercise · Restricted Stock Units | −4,903 | 9,807 | ||
| 2026-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Option exercise | +6,547 | 27,050 | ||
| 2026-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Shares withheld for taxes | −2,019 | $72.40 | $146K | 25,031 |
| 2026-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Returned to the company · Performance Stock Options (Right to Buy) | −22,545 | 1,879 | ||
| 2026-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Returned to the company · Performance Restricted Stock Units | −698 | 8,376 |
Page 2 of 32 · 626 trades